More than 10,000 seats allotted in final TG-EAPCET Bi.PC counselling
The final phase of Telangana’s 2026 Bi.PC counselling allotted 10,363 of 10,762 available seats, leaving 399 vacant. B.Pharmacy accounted for most places, while all Biomedical Engineering and Biotechnology seats were filled. Selected candidates must pay fees by September 30 and report to colleges by October 1.
A total of 10,363 seats were allotted in the final phase of Telangana’s web-based counselling for Bi.PC candidates who qualified in TGEAPCET 2026, leaving 399 of the 10,762 available seats vacant. The allotment rate was 96%, covering B.Pharmacy, Pharm.D, Pharmaceutical Engineering, Biomedical Engineering and Biotechnology courses for the 2026-27 academic year. According to the counselling data, B.Pharmacy had the largest allocation with 8,372 seats.
Pharm.D accounted for 1,669 seats. All 51 Biomedical Engineering seats and all 179 Biotechnology seats were filled. In Pharmaceutical Engineering, 92 of the 94 available seats were allotted.
The process also resulted in 484 candidates receiving allotments under the Economically Weaker Sections quota. Certificate verification was conducted on September 26, and candidates were permitted to exercise web options on September 26 and 27. Of the 16,797 candidates who attended certificate verification, 10,669 exercised web options.
The counselling process generated 2,96,777 options, according to the figures released after the final phase. The source material did not specify how the remaining vacant seats would be handled. Officials instructed candidates who received allotments to pay the prescribed fee by September 30.
They must also physically report to their allotted colleges by October 1. The final phase concluded the reported web-based counselling process for eligible Bi.PC candidates. The high allotment rate filled nearly all available places, including every seat in Biomedical Engineering and Biotechnology, while a small number remained unfilled in other courses.
This independently written report is based on information supplied by the named publisher. Vertrix News has not independently verified the source report.